Efficacy of human immunoglobulin injection and effects on serum inflammatory cytokines in neonates with acute lung injury

Wang,Shaohua; Tang,Zanmei; Zheng,Xuemei; Deng,Jian; Wang,Zhangxing

doi:10.3892/etm.2021.10363

Efficacy of human immunoglobulin injection and effects on serum inflammatory cytokines in neonates with acute lung injury

Authors:
- Shaohua Wang
- Zanmei Tang
- Xuemei Zheng
- Jian Deng
- Zhangxing Wang
View Affiliations

Affiliations: Neonatal Intensive Care Unit, Women and Children Health Institute of Futian, University of South China, Shenzen, Guangdong 518033, P.R. China, Neonatal Intensive Care Unit, Longhua People's Hospital, Shenzhen, Guangdong 518109, P.R. China
Published online on: July 1, 2021 https://doi.org/10.3892/etm.2021.10363
Article Number: 931
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study aimed to explore the efficacy of intravenous immunoglobulin (IVIG) injection in neonates with acute lung injury (ALI) and assess its effects on serum inflammatory cytokine levels. The research subjects were 140 neonates with ALI who were evenly distributed into a control group (COG) and a study group (STG). The COG patients were treated routinely, whereas patients in the STG were administered IVIG in addition to the standard treatment received by the COG. The arterial partial pressure of oxygen (PaO₂), PaO₂/fraction of inspired oxygen (FIO2), mechanical ventilation time and hospitalization time were compared between the two groups. ELISA was used to determine the levels of interleukin‑6 (IL‑6) and tumor necrosis factor‑α (TNF‑α) in the patients before treatment and at 12, 24 and 36 h after treatment. The Kaplan‑Meier method was used to analyze the survival of the patients, including their survival for 30 days after treatment. The patients were divided into high and low cytokine expression groups based on their mean expression levels of serum IL‑6 and TNF‑α before treatment. After treatment, PaO₂ and PaO₂/FiO2 were significantly higher and mechanical ventilation and hospitalization time were reduced in the STG in comparison with the COG (all P<0.001). At 12, 24 and 36 h after treatment, serum IL‑6 and TNF‑α levels in the STG were lower than those in the COG (both P<0.05). The 30‑day survival rate after treatment was not significantly different between the two groups (P>0.05). The 30‑day survival rate in the high IL‑6 and high TNF‑α expression COG was lower than that in the low IL‑6 and low TNF‑α expression COG (both P<0.05). The results of the present study indicate that IVIG may improve pulmonary gas exchange, shorten the course of disease and reduce the inflammatory response in neonates with ALI.

View Figures

View References

1	Li Y, Wu R, Tian Y, Yu M, Tang Y, Cheng H and Tian Z: RAGE/NF-κB signaling mediates lipopolysaccharide induced acute lung injury in neonate rat model. Int J Clin Exp Med. 8:13371–13376. 2015.PubMed/NCBI
2	Jin Z, Chun Suen K and Ma D: Perioperative ‘remote’ acute lung injury: Recent update. J Biomed Res. 31:197–212. 2017.PubMed/NCBI View Article : Google Scholar
3	Rajasekaran S, Pattarayan D, Rajaguru P, Sudhakar Gandhi PS and Thimmulappa RK: MicroRNA regulation of acute lung injury and acute respiratory distress syndrome. J Cell Physiol. 231:2097–2106. 2016.PubMed/NCBI View Article : Google Scholar
4	Gupta S, Sankar J, Lodha R and Kabra SK: Comparison of prevalence and outcomes of pediatric acute respiratory distress syndrome using Pediatric Acute Lung Injury Consensus Conference criteria and Berlin definition. Front Pediatr. 6(93)2018.PubMed/NCBI View Article : Google Scholar
5	Perl M, Chung C-S, Perl U, Lomas-Neira J, de Paepe M, Cioffi WG and Ayala A: Fas-induced pulmonary apoptosis and inflammation during indirect acute lung injury. Am J Respir Crit Care Med. 176:591–601. 2007.PubMed/NCBI View Article : Google Scholar
6	Perez EE, Orange JS, Bonilla F, Chinen J, Chinn IK, Dorsey M, El-Gamal Y, Harville TO, Hossny E, Mazer B, et al: Update on the use of immunoglobulin in human disease: A review of evidence. J Allergy Clin Immunol. 139:S1–S46. 2017.PubMed/NCBI View Article : Google Scholar
7	Wang Y and Scott DE: Development of a complement-mediated hemolysis assay for Immune globulin intravenous products and characterization of lots associated with clinical hemolysis. 2017.
8	Shulman ST: Intravenous immunoglobulin for the treatment of Kawasaki disease. Pediatr Ann. 46:e25–e28. 2017.PubMed/NCBI View Article : Google Scholar
9	Tagami T, Matsui H, Fushimi K and Yasunaga H: Intravenous immunoglobulin use in septic shock patients after emergency laparotomy. J Infect. 71:158–166. 2015.PubMed/NCBI View Article : Google Scholar
10	Rayamajhi A, Nightingale S, Bhatta NK, Singh R, Kneen R, Ledger E, Bista KP, Lewthwaite P, Mahaseth C, Turtle L, et al: A preliminary randomized double blind placebo-controlled trial of intravenous immunoglobulin for Japanese encephalitis in Nepal. PLoS One. 10(e0122608)2015.PubMed/NCBI View Article : Google Scholar
11	Fakhari Z, Farsaei S and Sabzghabaee AM: Predicting factors for the pattern of intravenous immunoglobulin utilization in a Middle Eastern University Hospital. J Res Pharm Pract. 7:188–194. 2018.PubMed/NCBI View Article : Google Scholar
12	Hartung HP, Mouthon L, Ahmed R, Jordan S, Laupland KB and Jolles S: Clinical applications of intravenous immunoglobulins (IVIg) - beyond immunodeficiencies and neurology. Clin Exp Immunol. 158 (Suppl 1):23–33. 2009.PubMed/NCBI View Article : Google Scholar
13	Jing W, Chunhua M and Shumin W: Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro. Toxicol Appl Pharmacol. 285:128–135. 2015.PubMed/NCBI View Article : Google Scholar
14	Jiang W, Luo F, Lu Q, Liu J, Li P, Wang X, Fu Y, Hao K, Yan T and Ding X: The protective effect of Trillin LPS-induced acute lung injury by the regulations of inflammation and oxidative state. Chem Biol Interact. 243:127–134. 2016.PubMed/NCBI View Article : Google Scholar
15	Mokra D and Kosutova P: Biomarkers in acute lung injury. Respir Physiol Neurobiol. 209:52–58. 2015.PubMed/NCBI View Article : Google Scholar
16	Altirkawi K: Surfactant therapy: The current practice and the future trends. Sudan J Paediatr. 13:11–22. 2013.PubMed/NCBI
17	Demirakça S, Dötsch J, Knothe C, Magsaam J, Reiter HL, Bauer J and Kuehl PG: Inhaled nitric oxide in neonatal and pediatric acute respiratory distress syndrome: Dose response, prolonged inhalation, and weaning. Crit Care Med. 24:1913–1919. 1996.PubMed/NCBI View Article : Google Scholar
18	Lai D, Xia J, Wang J, Wei X, Qian J, Lou Q, Ren X and Huang X: The effect of paraquat on voltage-dependent anion channel and caspase-3, 8, 9 in the mitochondria of rat lung. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 33:363–365. 2015.PubMed/NCBI(In Chinese).
19	Zimmermann KK, Spassov SG, Strosing KM, Ihle PM, Engelstaedter H, Hoetzel A and Faller S: Hydrogen sulfide exerts anti-oxidative and anti-inflammatory effects in acute lung injury. Inflammation. 41:249–259. 2018.PubMed/NCBI View Article : Google Scholar
20	Li SJ, Wang XJ, Hu JB, Kang XQ, Chen L, Xu XL, Ying XY, Jiang SP and Du YZ: Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy. Drug Deliv. 24:402–413. 2017.PubMed/NCBI View Article : Google Scholar
21	Becker DE: Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog. 60:25–31; quiz 32. 2013.PubMed/NCBI View Article : Google Scholar
22	Navegantes KC, de Souza Gomes R, Pereira PA, Czaikoski PG, Azevedo CH and Monteiro MC: Immune modulation of some autoimmune diseases: The critical role of macrophages and neutrophils in the innate and adaptive immunity. J Transl Med. 15(36)2017.PubMed/NCBI View Article : Google Scholar
23	Gadian J, Kirk E, Holliday K, Lim M and Absoud M: Systematic review of immunoglobulin use in paediatric neurological and neurodevelopmental disorders. Dev Med Child Neurol. 59:136–144. 2017.PubMed/NCBI View Article : Google Scholar
24	Ma XY, Li Z, Wang XJ, Ye JJ, Ma YP and Li Y: Clinical efficacy of different doses of gamma globulin combined with glucocorticoid in treatment of moderate/severe acute Guillain-Barré syndrome in children: A comparative analysis. Zhongguo Dang Dai Er Ke Za Zhi. 18:1286–1290. 2016.PubMed/NCBI View Article : Google Scholar : (In Chinese).
25	Viasus D, Garcia-Vidal C, Simonetti AF, Dorca J, Llopis F, Mestre M, Morandeira-Rego F and Carratalà J: The effect of simvastatin on inflammatory cytokines in community-acquired pneumonia: A randomised, double-blind, placebo-controlled trial. BMJ Open. 5(e006251)2015.PubMed/NCBI View Article : Google Scholar
26	Fang Y, Xu P, Gu C, Wang Y, Fu XJ, Yu WR and Yao M: Ulinastatin improves pulmonary function in severe burn-induced acute lung injury by attenuating inflammatory response. J Trauma. 71:1297–1304. 2011.PubMed/NCBI View Article : Google Scholar
27	Gao M, Xie B, Gu C, Li H, Zhang F and Yu Y: Targeting the proinflammatory cytokine tumor necrosis factor-α to alleviate cardiopulmonary bypass-induced lung injury (review). Mol Med Rep. 11:2373–2378. 2015.PubMed/NCBI View Article : Google Scholar
28	Massey VL, Poole LG, Siow DL, Torres E, Warner NL, Schmidt RH, Ritzenthaler JD, Roman J and Arteel GE: Chronic alcohol exposure enhances lipopolysaccharide-induced lung injury in mice: Potential role of systemic tumor necrosis factor-alpha. Alcohol Clin Exp Res. 39:1978–1988. 2015.PubMed/NCBI View Article : Google Scholar
29	Kang S, Tanaka T and Kishimoto T: Therapeutic uses of anti-interleukin-6 receptor antibody. Int Immunol. 27:21–29. 2015.PubMed/NCBI View Article : Google Scholar
30	Wang L, Chen Q, Shi C, Lv H, Xu X and Yu L: Changes of serum TNF-α, IL-5 and IgE levels in the patients of mycoplasma pneumonia infection with or without bronchial asthma. Int J Clin Exp Med. 8:3901–3906. 2015.PubMed/NCBI
31	Han CL and Zhao SL: Intravenous immunoglobulin gamma (IVIG) versus IVIG plus infliximab in young children with Kawasaki disease. Med Sci Monit. 24:7264–7270. 2018.PubMed/NCBI View Article : Google Scholar
32	Chu L, Zhu F, Zhou W, Du Z, Li J, Wang X, Wang L and Liu A: Baicalein attenuates acute lung injury induced by intestinal ischemia/reperfusion via inhibition of nuclear factor-κB pathway in mice. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 29:228–232. 2017.PubMed/NCBI View Article : Google Scholar : (In Chinese).
33	Wang Y, Gao L, Yang Z, Chen F and Zhang Y: Effects of probiotics on ghrelin and lungs in children with acute lung injury: A double-blind randomized, controlled trial. Pediatr Pulmonol. 53:197–203. 2018.PubMed/NCBI View Article : Google Scholar
34	Galli SJ, Tsai M and Piliponsky AM: The development of allergic inflammation. Nature. 454:445–454. 2008.PubMed/NCBI View Article : Google Scholar
35	Deshmane SL, Kremlev S, Amini S and Sawaya BE: Monocyte chemoattractant protein-1 (MCP-1): An overview. J Interferon Cytokine Res. 29:313–326. 2009.PubMed/NCBI View Article : Google Scholar